Aetna Inc (AET) Holdings Decreased by First Citizens Bank & Trust Co.
First Citizens Bank & Trust Co. lessened its holdings in shares of Aetna Inc (NYSE:AET) by 24.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 6,128 shares of the company’s stock after selling 1,946 shares during the quarter. First Citizens Bank & Trust Co.’s holdings in Aetna were worth $1,105,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of the business. Wells Fargo & Company MN raised its position in shares of Aetna by 4.2% in the 3rd quarter. Wells Fargo & Company MN now owns 1,365,596 shares of the company’s stock worth $217,144,000 after buying an additional 54,928 shares during the period. Fayez Sarofim & Co. raised its position in shares of Aetna by 82.8% in the 3rd quarter. Fayez Sarofim & Co. now owns 7,427 shares of the company’s stock worth $1,181,000 after buying an additional 3,365 shares during the period. California Public Employees Retirement System raised its position in shares of Aetna by 9.4% in the 3rd quarter. California Public Employees Retirement System now owns 910,189 shares of the company’s stock worth $144,729,000 after buying an additional 78,363 shares during the period. Prudential Financial Inc. raised its position in shares of Aetna by 3.6% in the 3rd quarter. Prudential Financial Inc. now owns 1,089,269 shares of the company’s stock worth $173,205,000 after buying an additional 38,223 shares during the period. Finally, Orbimed Advisors LLC raised its position in shares of Aetna by 57.3% in the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after buying an additional 508,600 shares during the period. 87.80% of the stock is currently owned by institutional investors.
Aetna Inc (AET) opened at $184.21 on Friday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. Aetna Inc has a 52-week low of $116.04 and a 52-week high of $192.37. The company has a market capitalization of $60,070.00, a PE ratio of 34.05, a price-to-earnings-growth ratio of 1.64 and a beta of 0.61.
Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating the consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. During the same period last year, the company posted $2.07 earnings per share. The firm’s revenue was down 5.0% compared to the same quarter last year. equities research analysts anticipate that Aetna Inc will post 9.78 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.09%. The ex-dividend date is Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is presently 36.97%.
Several research analysts recently weighed in on AET shares. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $174.00 target price on the stock in a research report on Thursday, October 12th. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Piper Jaffray Companies raised Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 target price on the stock in a research report on Wednesday, January 3rd. Argus lowered Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price on the stock. in a research report on Wednesday, December 6th. Finally, Morgan Stanley lowered Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price on the stock. in a research report on Wednesday, December 20th. Twelve investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $172.64.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with Analyst Ratings Network's FREE daily email newsletter.